Alyssa Levin
Director of Finance/CFO at NKARTA, INC.
Net worth: - $ as of 2024-04-29
Alyssa Levin active positions
Companies | Position | Start | End |
---|---|---|---|
NKARTA, INC. | Director of Finance/CFO | 2023-07-04 | - |
Career history of Alyssa Levin
Former positions of Alyssa Levin
Companies | Position | Start | End |
---|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director of Finance/CFO | - | 2023-07-04 |
Training of Alyssa Levin
University of British Columbia | Undergraduate Degree |
Edwards School of Business | Graduate Degree |
Statistics
International
United States | 3 |
Canada | 3 |
Operational
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NKARTA, INC. | Health Technology |
Private companies | 1 |
---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Alyssa Levin
- Experience